OTCMKTS:IZOZF Izotropic (IZOZF) Stock Price, News & Analysis → Elon’s New A.I. Device is About to Shock the World (From InvestorPlace) (Ad) Free IZOZF Stock Alerts $0.09 0.00 (0.00%) (As of 04/29/2024 ET) Add Compare Share Share Today's Range$0.09▼$0.0950-Day Range$0.08▼$0.1152-Week Range$0.05▼$0.28Volume7,505 shsAverage Volume22,390 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Izotropic alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About Izotropic Stock (OTCMKTS:IZOZF)Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.Read More IZOZF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IZOZF Stock News HeadlinesApril 25, 2024 | americanbankingnews.comIzotropic (OTCMKTS:IZOZF) Trading 32.2% Higher April 18, 2024 | finance.yahoo.comIzotropic Corporation (1R3.F)April 30, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” January 30, 2024 | finance.yahoo.comIzotropic Receives Response From U.S. FDAJanuary 8, 2024 | finance.yahoo.comIzotropic Provides Regulatory and Operational UpdatesNovember 11, 2023 | morningstar.comIzotropic Corp IZONovember 9, 2023 | morningstar.comIzotropic Corp IZOZFNovember 1, 2023 | finanznachrichten.deIzotropic Corporation: Izotropic Completes Pre-Submission Meeting with U.S. FDAApril 30, 2024 | InvestorPlace (Ad)Elon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” November 1, 2023 | finance.yahoo.comIzotropic Completes Pre-Submission Meeting with U.S. FDASeptember 27, 2023 | finance.yahoo.comIzotropic Confirms FDA Pre-Submission Meeting DateSeptember 20, 2023 | finance.yahoo.comIzotropic Closes Non-Brokered Private PlacementSeptember 6, 2023 | finance.yahoo.comIzotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate DevicesJune 20, 2023 | finance.yahoo.comIzotropic Modifies Market Approval Pathway & StrategyJune 8, 2023 | finance.yahoo.comIzotropic CEO ResignsMarch 17, 2023 | ca.finance.yahoo.comIzotropic Corporation (IZOZF)February 23, 2023 | finance.yahoo.comIzotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT TechnologyFebruary 22, 2023 | finance.yahoo.comIzotropic Corporation (IZOZF) Stock Historical Prices & Data - Yahoo FinanceFebruary 19, 2023 | marketwatch.comIsotropic Graphite Market is Expected to Experience an Upward Trend in Terms of Growth and Expansion Forecast 2028January 9, 2023 | finance.yahoo.comIzotropic Releases First Video of IzoViewJanuary 5, 2023 | ca.finance.yahoo.comIzotropic Corporation (IZO.CN)January 4, 2023 | finance.yahoo.comIzotropic Reports Board Meeting ResultsDecember 1, 2022 | finanznachrichten.deIzotropic Corporation: Izotropic Completes IzoView Development and Assembly, Prepares for Final TestingDecember 1, 2022 | finance.yahoo.comIzotropic Completes IzoView Development and Assembly, Prepares for Final TestingNovember 11, 2022 | finanznachrichten.deIzotropic Corporation: Alexander Tokman Joins Izotropic Board of DirectorsNovember 11, 2022 | finance.yahoo.comAlexander Tokman Joins Izotropic Board of DirectorsOctober 25, 2022 | finance.yahoo.comIzotropic's IzoView Is Weeks Away from Final Engineering & Showcasing to Investment and Scientific CommunitiesSee More Headlines Receive IZOZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Izotropic and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:IZOZF CUSIPN/A CIKN/A Webizocorp.com Phone833-496-2677FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Robert Louis Thast (Age 70)Founder, Interim CEO & Chairman Comp: $162.34kMr. Ralph F. Proceviat CPA (Age 74)Director & Interim CFO Dr. Younes Achkire Ph.D.Executive VP of Product Engineering & COOMr. Ali Reza SodagarLegal Advisor & Independent DirectorMs. Jaclyn ThastOperations Manager & Corporate SecretaryKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors IZOZF Stock Analysis - Frequently Asked Questions How have IZOZF shares performed in 2024? Izotropic's stock was trading at $0.0782 on January 1st, 2024. Since then, IZOZF shares have increased by 13.2% and is now trading at $0.0885. View the best growth stocks for 2024 here. How do I buy shares of Izotropic? Shares of IZOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IZOZF) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Izotropic Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
